Evidence map›Paper›PMID 27829157›Full record

ArticleCell reports2016

Two Distinct Pathways Support Gene Correction by Single-Stranded Donors at DNA Nicks.

Luther Davis, Nancy Maizels

Abstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Strategies for precise gene edits in mammalian cells.Molecular therapy. Nucleic acids · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. POLQ suppresses interhomolog recombination and loss of heterozygosity at targeted DNA breaks.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Luther DavisDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Nancy MaizelsDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Biochemistry, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address: maizels@u.washington.edu.

Funding

Genomic Instability at DNA NicksR01CA183967 · NCI · UNIVERSITY OF WASHINGTON · PI MAIZELS, NANCY · 2014 to 2018
$1.6M
Mechanisms of loss of heterozygosity in cancerR21CA190675 · NCI · UNIVERSITY OF WASHINGTON · PI MAIZELS, NANCY · 2015 to 2016
$370k
NCI NIH HHS R01 CA183967NCI NIH HHS R21 CA190675
6 · The paper itself

Abstract

Nicks are the most common form of DNA damage. The mechanisms of their repair are fundamental to genomic stability and of practical importance for genome engineering. We define two pathways that support homology-directed repair by single-stranded DNA donors. One depends upon annealing-driven strand synthesis and acts at both nicks and double-strand breaks. The other depends upon annealing-driven heteroduplex correction and acts at nicks. Homology-directed repair via these pathways, as well as mutagenic end joining, are inhibited by RAD51 at nicks but largely independent of RAD51 at double-strand breaks. Guidelines for coordinated design of targets and donors for gene correction emerge from definition of these pathways. This analysis further suggests that naturally occurring nicks may have significant recombinogenic and mutagenic potential that is normally inhibited by RAD51 loading onto DNA, thereby identifying a function for RAD51 in maintenance of genomic stability.

Indexed as

DNA DamageGene EditingBiomarkersDNA Breaks, Double-StrandedDNA Breaks, Single-StrandedDNA, Single-StrandedHEK293 CellsHumansRad51 RecombinaseRecombinational DNA RepairReplication Protein ABiomarkersDNA, Single-StrandedRad51 RecombinaseReplication Protein Abreast cancerdeletionDNA double-strand breakDNA single-strand breakgene correctiongene therapygenome engineeringmutagenesisrecombinationreplication

Identifiers

PMID27829157
PMCPMC5108528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.